ロード中...
Protease and cyclooxygenase inhibitors synergistically prevent activation of human platelets.
Thrombin induces platelet aggregation and formation of a fibrin clot in platelet-rich plasma; leupeptin, a protease inhibitor, partially inhibits platelet aggregation, but it does not inhibit fibrin clot formation. Indomethacin does not inhibit either thrombin-induced platelet aggregation or fibrin...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
1986
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC323534/ https://ncbi.nlm.nih.gov/pubmed/3458190 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|